Email This Page

U.S. Department of Health and Human Services • National Institutes of Health

Advanced Search

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on. Read more information on enabling JavaScript.

Email this page

back to previous page

Please provide the information requested below and click the "Submit" button.

Title	Q & A: NEJM Article on the SMART Study: CD4+ Count-Guided Episodic Antiretroviral Therapy for HIV Disease Associated with Poor Clinical Outcomes and No Reduced Risk of Adverse Events
Link	http://www.niaid.nih.gov/news/QA/Pages/NEJMsmart_QA.aspx
Recipient's Name
Recipient's Email (required)
Your Name
Your Email (required)
	Send a copy to myself

Note: We will not use your email address for future mailings or provide your address to third parties. The information will not be stored or used for any other purpose. Please see our Privacy Policy for more information.

U.S. Department of Health and Human Services Text